A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers
CFKL480A02101
Phase 1 other active
Quick answer
A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers for Advanced breast cancer and advanced NSCLC is a Phase 1 program (other) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Advanced breast cancer and advanced NSCLC
- Phase
- Phase 1
- Modality
- other
- Status
- active